Day 2 at #ENETS2026:
A full day of clinical #NEN research, from systemic therapy and #PPGL management to #AI in #NET care. Cutting-edge findings were presented in oral and mini-oral abstract sessions, followed by the new moderated Poster Stage Presentations.
Thank you to our excellent faculty and everyone who joined our engaging ENETS #PPGL webinar yesterday!
The video recording is now available: www.enets.org/webinar/webi...
Participants can earn up to 1 ECMEC® credit after completing the feedback survey. Contact the ENETS Office for your certificate.
Last call to join today’s #ENETS #webinar on advanced management of pheochromocytomas and paragangliomas (PPGL).
28 Jan 2026 | 18:00–19:10 CET | Zoom
Register here: us06web.zoom.us/webinar/regi...
View agenda: www.enets.org/webinar/webi...
#EACCMEaccredited #PPGL
Join us tomorrow for the first #ENETS #webinar of 2026 to be updated on the latest advances in pheochromocytomas and paragangliomas (PPGL).
28 Jan 2026 | 18:00–19:10 CET | Zoom
Register here: us06web.zoom.us/webinar/regi...
View agenda: www.enets.org/webinar/webi...
#EACCMEaccredited #PPGL
Don’t forget to sign up for next week’s high-level #ENETS #webinar, featuring leading experts on pheochromocytomas and paragangliomas (PPGL).
28 Jan 2026 | 18:00–19:10 CET | Zoom
Register: us06web.zoom.us/webinar/regi...
More information: www.enets.org/webinar/webi...
#EACCMEaccredited #PPGL
Privileged to take part in the 1st #VHL Alliance Research Forum in Charlotte, NC. Together, we explored future opportunities in VHL #CancerResearch.
Thank you, VHL Alliance and the Rath Family, for this inspiring meeting! We will continue studying VHL- #PNET and #PPGL! 🚀
#RareDisease #Oncology
Great time at #ISP2025 in Montréal representing the #ENSAT community together with many others. Honoured to present our @unibirmingham.bsky.social project on #machinelearning #webapp for prediction of #metastasis in #pheo #PPGL 🙏 to the LOC for organising an amazing event! #EndoSky #MedSky #adrenal
🙏 With fantastic collaborators incl. @ChrisJuhlin, @MichaelMints & team!
#PPGL #CancerResearch #TumorOrigin #StemCells #SingleCell
Interested in paraganglioma, progenitors, and tumor cells of origin?
Postnatal SOX2⁺ sustentacular glia as chromaffin progenitors can serve as tumor cells of origin in VHL-mutated paragangliomas:
www.researchsquare.com/article/rs-6...
#PPGL #CancerResearch #StemCells #TumorOrigin #SingleCell
Happy to share the podium with fabulous colleagues in #PPGL Dr Hans Ghayee & Dr Judith Favier. Great to hear their new work in metabolomics & microenvironment. & happy to share our PPGL genetic modifier results.
@cuendocrinology.bsky.social
#ENDO2025
📢 We are thrilled to announce that applications for the #ENSAT Scientific Awards 2025 are now open! Two awards for each category WG (#ACC, #APA, #NAPACA, #PPGL) and one for KIDS WG. Don't miss the deadline 21/07/2025.
Criteria and details available at ensat.org.
Such a fantastic, inclusive and supportive community. Together with our incredible speakers, staff and volunteers, they make the Annual Information Day so special! Huge thanks to all involved. Until next year all!
#MEN1 #MEN2 #MEN3 #PPGL #ACC.
Just one week left to book FREE 2025 Annual Patient Information Day tickets! Central London, Saturday 31st May. Check out our website for programme and bookings.
www.amend.org.uk/patients/sup...
#MEN1 #MEN2 #MEN2A #MEN2B #PPGL #phaeopara #pheopara #ACC #adrenocorticalcancer #patientinformation
‼️ Just one month to go until our 2025 Annual Patient Information Day! FREE event for patients with multiple endocrine neoplasia, inherited paraganglioma syndromes and adrenocortical cancer. 💛
www.amend.org.uk/patients/sup...
#MEN #PPGL #ACC #patienteducation
💛 AMEND Annual Patient Information Day 2025 extras! Adrenal insufficiency workshop, benefits helpdesk, information tables, and free lunch and refreshments for networking. FREE event for patients, Sat 28 May, London
📲 www.amend.org.uk/patients/sup...
#MENsyndromes #PPGL #ACC #patienteducation
Today is World Hormone Day! Get involved to highlight the importance of hormones, and the recommendations for good hormone health 📲 www.amend.org.uk/world-hormon...
#worldhormoneday2025 #endocrinediseases #MEN1 #MEN2 #MEN2A #MEN2B #PPGL #MTC #ACC #neuroendocrinecancer #rarediseases
💛 AMEND Annual Patient Information Day 2025 superb experts in endocrine and head and neck paraganglioma surgery, speaking just after lunch. FREE event for patients, Sat 28 May, London, for MEN, PPGL and ACC.
www.amend.org.uk/patients/sup...
#MENsyndromes #PPGL #ACC
💛 AMEND Annual Patient Information Day 2025 superb line-up of medical experts for our morning Q&A sessions! FREE event for patients with MEN, PPGL, and ACC, Sat 28th May, London
www.amend.org.uk/patients/sup...
#MEN1 #MEN2A #MEN2B #PPGL #ACC
🚨Registration for the joint annual #ENSAT and #Harmonis@tion meeting is OPEN!!! Abstract submission deadline for travel grants is April 15! Check link below and spread the news! ‼️🔗👇
#Cushing #adrenalcancer #ACC #primaryaldo #PPGL #network #research #adrenaltumour
goharmonisation.com/final-conferen…
Membership of AMEND is free to anyone affected by MEN or PPGL syndromes, MTC and ACC, as well as to health professionals: www.amend.org.uk/patients/joi...
#MEN1 #MEN2 #MEN3 #MEN2A #MEN2B #PPGL #paraganglioma #phaeochromocytoma #Adrenocorticalcancer #ACC #MTC #medullarythyroidancer
Multiracial hands holding colourful jigsaw pieces surrounding the message 'together we are stronger' under the AMEND logo
Our AMEND BlueSky account now includes all our communities: multiple endocrine neoplasia syndromes, phaeochromocytoma and paraganglioma syndromes, medullary thyroid cancer, and adrenocortical cancer. Our separate accounts for PPGL and ACC have been deactivated.
#MEN1 #MEN2 #MEN3 #ACC #PPGL
